tiprankstipranks
Trending News
More News >
Acme United Corporation. (ACU)
XASE:ACU
US Market

Acme United (ACU) Earnings Dates, Call Summary & Reports

Compare
183 Followers

Earnings Data

Report Date
Apr 17, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.4
Last Year’s EPS
0.41
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 26, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presents a generally positive outlook: the company achieved record sales and earnings, generated strong free cash flow, reduced net debt, grew in Canada and Europe, and made strategic investments (M&A, facilities, automation) to expand first aid and medical capabilities. However, growth is modest (1% year-over-year), U.S. revenues were flat to slightly down, Q4 gross margin saw slight compression, and the business faced meaningful tariff-related disruptions and integration risks from acquisitions. Overall, the operational execution, cash generation, margin discipline and strategic positioning outweigh the near-term headwinds and risks.
Company Guidance
Acme said its guidance is for growth in its first aid and medical segments and a return to more normal retail merchandising and promotion in 2026, and management expects to “deliver good results” in Q1 and the rest of the year as it leverages expanded domestic production and international sourcing. The company enters 2026 after record 2025 results — net sales $196.5M, net income $10.2M, EPS $2.49 — with Q4 sales of $47.5M (+3% YoY) and year sales up 1%; segment strength includes Europe +22% (quarter, local currency) and Canada +14% (quarter, local currency), while U.S. sales were flat in Q4 and down 1% for the year. Financial and strategic capacity to grow is supported by a 39.4% FY gross margin, Q4 operating profit up 27%, SG&A at $62.7M (32% of sales) for the year, interest expense down to $1.6M, bank debt less cash of $18.5M, $13M of free cash flow before the $6M Tennessee facility purchase (78,000 sq ft), recent acquisitions (My Medic: ~$19M 2025 revenue, $18.6M purchase price with ~$1M earn-out and ~$3M holdback; a Germany cutting line for $1.6M with ~$2M annual sales), and ongoing investments in robotics, Med‑Nap capacity, a microbiology lab and inventory optimization.
Record Sales and Earnings
Net sales for 2025 were $196.5 million (up from $194.5 million in 2024, +1%). Net income was $10.2 million ($2.49 diluted EPS) compared to $10.0 million ($2.45 EPS) in 2024, representing a 2% increase in net income and EPS for the year. Q4 net sales were $47.5 million (up 3% vs. Q4 2024) and Q4 net income was $1.9 million ($0.46 diluted EPS), up 10% in net income and 12% in diluted EPS versus Q4 2024.
Strong Operational Cash Generation and Deleveraging
Generated approximately $13 million in free cash flow during the 12-month period (before the $6 million Tennessee facility purchase). Net bank debt less cash improved to $18.5 million on Dec 31, 2025, down from $21.5 million a year earlier. Interest expense declined from $1.9 million to $1.6 million due to lower debt and rates.
Margin and Expense Discipline
Full-year gross margin was 39.4% (up slightly from 39.3% in 2024). Q4 gross margin was 38.2% (a modest 0.5 percentage-point decline vs. Q4 2024), while SG&A improved in Q4 to $15.2 million or 32% of sales (vs. $15.5 million or 34% in Q4 2024). Operating profit in Q4 increased 27% year-over-year.
Geographic and Category Growth
Europe net sales increased 22% in local currency in the quarter and 4% for the year (benefiting from the Oct 1 acquisition of cutting and sharpening tools). Canada net sales rose 14% in the quarter and 16% for the year, driven by strong first aid product sales. U.S. first aid and medical product sales were strong despite flat overall U.S. sales.
Strategic M&A and Asset Investments
Acquired My Medic in Jan 2026 (approximate 2025 revenues $19M; purchase price ~$18.7M with $1M earn-out and $3M holdback). Acquired German cutting/sharpening business Oct 2025 (annual sales ~$2M; purchase price $1.6M). Purchased a 78,000 sq ft Tennessee facility for ~$6M to expand Spill Magic and blood-borne pathogen kit production and invested in Med-Nap capacity and microbiology lab preparations for medical-grade domestic supply.
Product & Technology Innovations
Introduced a patented automatic replenishment system for industrial first aid refills (projected customer savings of 30%–50%+ vs. traditional van-based delivery). Expanded nonstick and ceramic cutting tool lines, invested in robotics at three U.S. sites, implemented inventory optimization software and nightly drone inventory reconciliation at Rocky Mount, NC.
Supply Chain Agility and Sourcing Diversification
Responded rapidly to tariff changes by moving over 50 containers when China tariffs were reduced (from 145% to 30%), broadened manufacturing to Vietnam, Thailand, Malaysia, India and Egypt, and negotiated supplier cost reductions and lower freight rates to support customer orders and preserve margins.

Acme United (ACU) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ACU Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 17, 2026
2026 (Q1)
0.40 / -
0.41
Feb 26, 2026
2025 (Q4)
0.42 / 0.46
0.4112.20% (+0.05)
Oct 21, 2025
2025 (Q3)
0.54 / 0.46
0.54-14.81% (-0.08)
Jul 23, 2025
2025 (Q2)
0.50 / 1.16
1.096.42% (+0.07)
Apr 17, 2025
2025 (Q1)
0.53 / 0.41
0.395.13% (+0.02)
Feb 28, 2025
2024 (Q4)
0.48 / 0.41
0.42.50% (<+0.01)
Oct 18, 2024
2024 (Q3)
0.73 / 0.54
0.58-6.90% (-0.04)
Jul 19, 2024
2024 (Q2)
0.94 / 1.09
0.9613.54% (+0.13)
Apr 19, 2024
2024 (Q1)
0.36 / 0.39
0.2839.29% (+0.11)
Mar 01, 2024
2023 (Q4)
0.55 / 0.40
-0.17335.29% (+0.57)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ACU Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 21, 2025
$38.30$37.60-1.82%
Jul 23, 2025
$41.32$43.10+4.30%
Apr 17, 2025
$39.62$40.90+3.24%
Feb 28, 2025
$37.17$38.49+3.55%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Acme United Corporation. (ACU) report earnings?
Acme United Corporation. (ACU) is schdueled to report earning on Apr 17, 2026, Before Open (Confirmed).
    What is Acme United Corporation. (ACU) earnings time?
    Acme United Corporation. (ACU) earnings time is at Apr 17, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ACU EPS forecast?
          ACU EPS forecast for the fiscal quarter 2026 (Q1) is 0.4.